Own blood product and steroid injections in frozen shoulder

Not Applicable

• Conditions: Health Condition 1: M255- Pain in jointHealth Condition 2: null- Patients with adhesive capsulitis

• Registration Number: CTRI/2017/08/009454
• Lead Sponsor: All India Institute of Medical Sciences Bhubaneswar

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1)Patients attending PMR OPD, AIIMS BBSR and diagnosed as having unilateral adhesive capsulitis of either shoulder, as per criteria mentioned below, with duration of symptoms less than 6 months. Diagnosis of adhesive capsulitis would be according to the following criteria:

i)The presence of shoulder pain

ii)Limitation of both active and passive movements of the glenohumeral joint of >=25% in at list 2 directions (abduction, flexion, external rotation, internal rotation), as compared with the contralateral shoulder

2)If bilateral shoulders are involved and qualify for inclusion, only the dominant arm would be considered for intervention.

3)Age between 18 and 70 years

Exclusion Criteria

1)Patients with inflammatory joint disease.

2)Patients who have previously undergone any intra-articular injection/invasive procedure/surgery in the shoulder joint.

3)Patients with structural/functional limitations in the shoulder joint from any other pre-existing musculoskeletal pathology or neurologic disorder.

4)Patients with poor cognitive status who are unable to follow exercise program

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome measure would be: <br/ ><br>1)Visual Analogue Scale (VAS)-Patient-reported Pain intensity in the shoulder joint <br/ ><br>2)SPDI (Shoulder pain and disability Index) <br/ ><br>3)Shoulder ROM- measured by GoniometryTimepoint: 12 weeks

Secondary Outcome Measures

Name	Time	Method
Secondary Outcome measure would be Patient Satisfaction Scale <br/ ><br>Timepoint: 12 weeks